Search Results Search Sort by RelevanceMost Recent Health Law Oct 2020 Effects of Substance Use Disorder Criminalization on American Indian Pregnant Individuals Rachel Simon, MD, Jennifer Giroux, MD, MPH, and Julie Chor, MD, MPH Clinicians must advocate for decriminalization of SUDs during pregnancy and for improving access to comprehensive, evidence-based care. AMA J Ethics. 2020;22(10):E862-867. doi: 10.1001/amajethics.2020.862. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements. Case and Commentary Jun 2011 Herbal Supplements as Placebos Valerie Jones, MD Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness. Virtual Mentor. 2011;13(6):354-358. doi: 10.1001/virtualmentor.2011.13.6.ccas3-1106. Case and Commentary Oct 2006 Coping with a Child's Conduct Disorder Sharon Hirsch, MD and Rebecca Sheffield A carefully constructed consent and treatment plan is outlined for a neglected and abused child hospitalized with a severe behavioral disorder. Virtual Mentor. 2006;8(10):654-658. doi: 10.1001/virtualmentor.2006.8.10.ccas3-0610.
Health Law Oct 2020 Effects of Substance Use Disorder Criminalization on American Indian Pregnant Individuals Rachel Simon, MD, Jennifer Giroux, MD, MPH, and Julie Chor, MD, MPH Clinicians must advocate for decriminalization of SUDs during pregnancy and for improving access to comprehensive, evidence-based care. AMA J Ethics. 2020;22(10):E862-867. doi: 10.1001/amajethics.2020.862.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
Case and Commentary Jun 2011 Herbal Supplements as Placebos Valerie Jones, MD Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness. Virtual Mentor. 2011;13(6):354-358. doi: 10.1001/virtualmentor.2011.13.6.ccas3-1106.
Case and Commentary Oct 2006 Coping with a Child's Conduct Disorder Sharon Hirsch, MD and Rebecca Sheffield A carefully constructed consent and treatment plan is outlined for a neglected and abused child hospitalized with a severe behavioral disorder. Virtual Mentor. 2006;8(10):654-658. doi: 10.1001/virtualmentor.2006.8.10.ccas3-0610.